Fragment screen against ABLE
Correy, G.J., Fraser, J.S.To be published.
Experimental Data Snapshot
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
De novo designed ABLE protein | 126 | synthetic construct | Mutation(s): 0  | ![]() | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
MWP Query on MWP | B [auth A] | 1-benzothiophen-6-amine 1,1-dioxide C8 H7 N O2 S KRUCRVZSHWOMHC-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 25.978 | α = 90 |
b = 46.977 | β = 102.95 |
c = 46.36 | γ = 90 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
Aimless | data scaling |
PDB_EXTRACT | data extraction |
XDS | data reduction |
PHASER | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) | United States | GM145238 |